IFNL2 and Lipedema: In the study conducted by Nankam et al. [8] they identified significantly higher level of circulating inflammatory proteins (IL-11, IL-28a, and IL-19) in individuals with lipedema compared to obese controls, supporting the presence of a pronounced systemic pro-inflammatory signature in lipedema that exceeds the well-established low-grade inflammation seen in obesity.